☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Alchemedicine Entered into an Exclusive License Agreement with Asahi Kasei Pharma for Endothelin A Receptor Antagonist to Treat Ch...
June 15, 2022
The EMA and HMA Acquired Big Data Strategy to Folster Veterinary Therapies in the EU
June 15, 2022
PharmaShots Interview: In Conversation with Leonard A. Farber and James Welsh, Where they Share Insights on How Nanoparticle can T...
June 15, 2022
Xenco Medical Expanded its ASC Surgical Device Portfolio with the Launch of Multilevel CerviKit
June 15, 2022
Pfizer Reports Updated Results of Paxlovid (nirmatrelvir and ritonavir) in the P-II/III (EPIC-SR) Trial for the Treatment of COVID...
June 15, 2022
Vyluma Entered into an Exclusive License Agreement with Théa for the Registration and Commercialization of NVK002 to Treat Myopia
June 15, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions